ATE332923T1 - Cr1 fragmente und deren verwendung - Google Patents

Cr1 fragmente und deren verwendung

Info

Publication number
ATE332923T1
ATE332923T1 AT97905126T AT97905126T ATE332923T1 AT E332923 T1 ATE332923 T1 AT E332923T1 AT 97905126 T AT97905126 T AT 97905126T AT 97905126 T AT97905126 T AT 97905126T AT E332923 T1 ATE332923 T1 AT E332923T1
Authority
AT
Austria
Prior art keywords
sequence
fragments
pharmaceutiocal
ggrkvf
felvgepsiy
Prior art date
Application number
AT97905126T
Other languages
English (en)
Inventor
Danuta Ewa Irena Mossakowska
Colin Michael Edge
Richard Anthony Godwin Smith
Original Assignee
Adprotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adprotech Ltd filed Critical Adprotech Ltd
Application granted granted Critical
Publication of ATE332923T1 publication Critical patent/ATE332923T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Disintegrating Or Milling (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
AT97905126T 1996-03-02 1997-02-26 Cr1 fragmente und deren verwendung ATE332923T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9604518.2A GB9604518D0 (en) 1996-03-02 1996-03-02 Novel compounds

Publications (1)

Publication Number Publication Date
ATE332923T1 true ATE332923T1 (de) 2006-08-15

Family

ID=10789768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905126T ATE332923T1 (de) 1996-03-02 1997-02-26 Cr1 fragmente und deren verwendung

Country Status (10)

Country Link
US (1) US6797806B2 (de)
EP (1) EP0900235B1 (de)
JP (1) JP4125373B2 (de)
AT (1) ATE332923T1 (de)
AU (1) AU724548B2 (de)
CA (1) CA2247998C (de)
DE (1) DE69736325T2 (de)
GB (1) GB9604518D0 (de)
NZ (1) NZ331733A (de)
WO (1) WO1997031944A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1327991A (zh) * 2000-06-12 2001-12-26 上海博德基因开发有限公司 一种新的多肽——补体受体12和编码这种多肽的多核苷酸
DE102009026259A1 (de) 2009-07-28 2011-02-03 Krones Ag Vorrichtung zum Erwärmen von Vorformlingen
EP2425959B1 (de) 2010-09-06 2013-07-31 Krones AG Vorrichtung sowie Verfahren zum Erwärmen von Vorformlingen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
EP0512733A2 (de) * 1991-05-03 1992-11-11 Washington University Modifizierter Komplementsystemregler
DE69328098T2 (de) * 1992-06-24 2000-08-24 Adprotech Plc Lösliche derivate des complement type-rezeptors (cr1)
GB9301289D0 (en) * 1993-01-22 1993-03-17 Smithkline Beecham Plc Novel composition

Also Published As

Publication number Publication date
DE69736325D1 (de) 2006-08-24
NZ331733A (en) 1999-10-28
DE69736325T2 (de) 2007-07-05
AU1879097A (en) 1997-09-16
EP0900235A1 (de) 1999-03-10
CA2247998C (en) 2008-10-21
AU724548B2 (en) 2000-09-28
US6797806B2 (en) 2004-09-28
EP0900235B1 (de) 2006-07-12
JP4125373B2 (ja) 2008-07-30
JP2000505307A (ja) 2000-05-09
US20020142372A1 (en) 2002-10-03
WO1997031944A1 (en) 1997-09-04
CA2247998A1 (en) 1997-09-04
GB9604518D0 (en) 1996-05-01

Similar Documents

Publication Publication Date Title
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
DE69732871D1 (de) Basisches Protein Zusammensetzung, basisches Peptid Zusammensetzung und deren Verwendung
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ATE273388T1 (de) Veränderte menschliche c3-proteine
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
DE69831257D1 (de) Histogranin peptide und deren analgetische verwendung
ATE332923T1 (de) Cr1 fragmente und deren verwendung
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
DE3674971D1 (en) P-acylaminobenzamide.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
ATE239499T1 (de) Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen
GB9723824D0 (en) Cytostatic agents
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
NO20000976L (no) Peptider
DE69939345D1 (de) Neuartiges polypeptid und dessen kodierende nukleinsäuren
ATE404576T1 (de) Neuartiges polypeptid und dessen kodierende nukleinsäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties